Trial Summary
The trial information does not specify whether participants need to stop taking their current medications.
Eye tracking can effectively distinguish children with autism from typically developing children by analyzing their eye movements and fixation times, achieving a classification accuracy of 85.1%. Additionally, eye tracking has been shown to detect high-functioning autism in adults with around 74% accuracy, indicating its potential as a useful tool for autism detection.
12345Eye tracking is considered safe for humans as it is non-invasive, meaning it doesn't require surgery or entering the body, and it doesn't involve any harmful procedures.
23467Eye tracking for autism detection is unique because it uses technology to monitor eye movements and visual processing differences, which can help identify autism without the need for traditional behavioral assessments. This method is non-invasive and can provide early detection, especially in children, by analyzing how they focus on different visual stimuli.
12358Eligibility Criteria
This trial is for young children aged 12-48 months who are patients at Riley Hospital for Children in Indiana. They must have caregivers who speak English or Spanish and can give consent. It's not open to kids younger than 12 months, older than 48 months, or those with non-English/Spanish-speaking caregivers.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Developmental Evaluation
Children undergo a standard of care developmental evaluation including a clinical interview and observational measures
Eye-Tracking Activity
Participants engage in a one-time eye-tracking activity to view pictures and movies while eye movements are tracked
Follow-up
Participants are monitored for safety and effectiveness after the eye-tracking activity